Skip to Main Navigation

The Indonesia private health sector: Opportunities for reform an analysis of obstacles and constraints to growth (Inglês)

The Indonesian health care system is inadequate to meet the needs of the country's population. Unless major changes can be effected and more emphasis is given to private healthcare, the adequacy of the system will continue to decline and the hard won gains in health status of the last three decades will be jeopardized. There is a need for new strategies and approaches to meet the healthcare needs of the Indonesian people in which private health care will play a larger role. This report describes the public and private provision of health care, discusses expenditures, hospital assets, the availability of health care personnel, health care infrastructure, health care training facilities, health care financing and taxation, foreign investment in the health sector, health care reform efforts, medical services demand, Ministry of Health capacity, and government subsidization in the health sector. The report offers near term and long terms recommendations.

Detalhes

  • Autor

    Marzolf,James R.

  • Data do documento

    2002/08/01

  • TIpo de documento

    Documento de Trabalho

  • No. do relatório

    34230

  • Nº do volume

    1

  • Total Volume(s)

    1

  • País

    Indonésia,

  • Região

    Leste Asiático e Pacífico,

  • Data de divulgação

    2005/11/10

  • Disclosure Status

    Disclosed

  • Nome do documento

    The Indonesia private health sector: Opportunities for reform an analysis of obstacles and constraints to growth

  • Palavras-chave

    managed care;Infant and Maternal Mortality Rates;private hospitals;private health care;public hospital;medical equipment and supplies;health expenditure per capita;quality of service results;private health care services;healthcare expenditure;public health care resources;vulnerable segments of society;private ambulatory care;health sector growth;hospital bed;private health expenditure;Public Facilities;state owned company;health care expenditure;state owned enterprise;value added tax;ambulatory care facilities;national health accounts;private hospital sector;per capita expenditure;constraints to growth;Population Growth;healthcare services;risk pool;Private Sector Growth;public health facility;health sector issues;lack of credit;private health clinics;health sector goods;foreign joint venture;health care professional;aggregate total expenditure;private health insurance;formal sector worker;income on health;international development agency;health sector policy;transfer of asset;foreign exchange risk;private sector involvement;public health center;economies of scale;public health system;healthrelated product;general hospital beds;medical service cost;equity of access;national healthcare priorities;health care system;cost recovery strategy;domestic private investment;classes of accommodation;hospital inpatient care;response to crisis;private sector employment;health insurance plan;national health strategies;access to capital;free trade agreement;ambulatory care provision;tax credit program;disparities in access;total private investment;health sector development;tax credit system;social insurance system;public system;government health;private expenditure;private service;primary care;utilization rate;Public Healthcare;public fund;private provision;healthcare professional;prescription drug;investment incentive;health post;private clinic;demographic change;private insurance;hospital service;Public Goods;commercial credit;Infectious Disease;pharmaceutical sector;production capacity;tertiary care;import tariff;official estimates;healthcare reform;financing system;curative care;diagnostic services;expenditure group;economic crisis;hospital autonomy;targeted subsidy;capital gain;healthcare system;product category;sole shareholder;generic drug;Public Services;reform effort;curative service;aging population;inadequate fund;medicinal herb;Capital Investments;government property;corporate taxation;health benefit;moral hazard;general practice;market segment;household survey;average cost;admission rate;clinical efficacy;government service;financial service;national survey;public expenditure;financial impact;regulatory body;Regulatory Bodies;disproportionate share;operational practices;infrastructure needs;vulnerable group;financial barrier;adequate services;Herbal remedies;drug regulatory;hospital fees;medical benefit;prescription medication;temporary contract;expenditure account;hospital expenditure;hospital plan;outpatient care;Mobile Health;increased access;specialist examination;pharmaceutical manufacturers;retail distribution;budgetary burden;drug store;government strategy;private doctors;small entities;license requirement;drug procurement;employment opportunity;commercial basis;consultative process;medical school;hospital providers;pharmaceutical manufacturing;urban dweller;labor pool;direct investment;life expectancy;limited resources;geographical conditions;rural counterpart;general practitioner;quality care;hospital organizations;income earner;financial incentive;financial abuse;pharmaceutical policy;affluent groups;health improvement;management service;government budget;traditional medicine;medical goods;economic stability;tax regulation;purchasing cooperative;shopping complexes;remote area;Natural Resources;public provider;niche market;compensation system;lab facility;Health Workers;trade restriction;medical laboratories;pharmaceutical expenditure;pharmaceutical infrastructure;market condition;private collaboration;private delivery

Downloads

COMPLETAR RELATÓRIO

Versão oficial do documento (pode conter assinaturas, etc.)

  • PDF oficial
  • TXT*
  • Total Downloads** :
  • Download Stats
  • *A versão do texto é um OCR incorreto e está incluído unicamente em benefício de usuários com conectividade lenta.